Summary
Elevance Health, Inc. (ELV) filed a Current Report (8-K) on January 28, 2026, to report its fourth quarter and full year 2025 financial results. The press release containing these results is furnished as an exhibit to this filing. Investors should note that the information provided in this 8-K, specifically within Item 2.02 and Exhibit 99.1, is furnished and not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. Consequently, this information will not be incorporated by reference into any future SEC filings unless explicitly stated. The report also includes a standard forward-looking statements disclaimer, outlining the inherent risks and uncertainties that could cause actual results to differ materially from any projections. Investors are advised to review the detailed risk factors discussed in Elevance Health's other SEC filings, as these forward-looking statements speak only as of the filing date and are not updated for subsequent events.
Key Highlights
- 1Elevance Health released its Q4 and Full Year 2025 financial results on January 28, 2026, via an 8-K filing.
- 2The detailed financial results are presented in a press release furnished as Exhibit 99.1.
- 3Information provided in this 8-K is furnished, not filed, meaning it does not automatically update future SEC filings.
- 4The filing includes a standard 'Forward-Looking Statements' section.
- 5Investors are cautioned about risks and uncertainties that could impact future financial performance.
- 6The report emphasizes that forward-looking statements are not guarantees and actual results may differ.
- 7Investors are encouraged to consult other Elevance Health SEC filings for a comprehensive understanding of risks.